Tilray Brands (TLRY) Cash from Investing Activities (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Tilray Brands | 454.65 Mn | 394.45 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 149.85% |
| Nov 30, 2025 | -337.07% |
| Aug 31, 2025 | 80.96% |
| May 31, 2025 | 11,462.18% |
| Feb 28, 2025 | 98.89% |
| Nov 30, 2024 | 78.29% |
| Aug 31, 2024 | -209.63% |
| May 31, 2024 | 60.42% |
| Feb 29, 2024 | -65.54% |
| Nov 30, 2023 | 409.99% |
| Aug 31, 2023 | -246.65% |
| May 31, 2023 | -65.16% |
| Feb 28, 2023 | 98.31% |
| Nov 30, 2022 | -17,557.64% |
| Aug 31, 2022 | 68.73% |
| May 31, 2022 | -379.04% |
| Feb 28, 2022 | 85.28% |
| Nov 30, 2021 | 19.12% |
| Aug 31, 2021 | -102.47% |
| Nov 30, 2020 | -1,950.46% |